This year’s recipient is Dr. Jean-Christophe Leroux, full Professor in Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at ETH Zurich.
“Professor Leroux is an innovative leader in the field of drug delivery, where his research group has made numerous advancements in clinical translation in this space,” says Theresa Reineke, Editor-in-Chief of Bioconjugate Chemistry. “We are very excited he has been selected as the 2023 Bioconjugate Chemistry Lectureship Awardee.”
Dr. Leroux was born in Montreal (Canada) in 1969. He received his B.Pharm. from the University of Montreal, followed by a Ph.D. in Pharmaceutical Sciences (1995) from the University of Geneva (Switzerland). From 1996 to 1997 he completed a postdoctoral training at the University of California, San Francisco and then joined the University of Montreal as an assistant professor. He was promoted to the ranks of associate professor in 2002 and full professor in 2007. In 2001, he was awarded the Canada Research Chair in Drug Delivery. Prof. Leroux joined the Institute of Pharmaceutical Sciences at ETHZ as ordinary professor at the end of 2008.
His research interests include the design of novel biopolymers, stimuli-responsive drug delivery systems (liposomes, micelles and gels) and the targeting of anticancer drugs. Recently he has been involved in the development of polymer therapeutics for Celiac disease. He is the author or coauthor of numerous refereed articles, book chapters and patents/patent applications in the field of drug delivery. He serves in the editorial board of several journals including the Journal of Controlled Release and Molecular Pharmaceutics. He has received several prestigious distinctions and fellowships including the CRS-Capsugel (1997 and 2003), AFPC-Astra Zeneca (2003) and CRS young investigator awards (2004) and the Steacie Fellowships (2008) for innovative research in pharmaceutical technology.
The award will be presented at ACS Fall 2023 in San Francisco, from August 13-17. Leroux will be presenting a lecture as part of the Bioconjugate Chemistry Lectureship Symposium at the meeting, along with other prominent researchers in the field.
For additional information, read the ACS Axial interview with Dr. Leroux.